Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Finding of Ropivacaine for Adductor Canal Block
NCT02541552Phase 3Completed
- Start
- Apr 2015
- Primary completion
- Nov 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of ropivacaine in postoperative pain. Primary endpoint: Effective Volume 50% (EV50) of anesthetic volume needed to produce >30% reduction of pre-injectate quadriceps strength at 20 months. Started Apr 2015; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02541552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541552.